AMEDISYS INC (AMED)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch AMED
See up to 3 months of AMED. The 7-day demo opens the 1M and 3M ranges and puts AMED on your watchlist.
Start 7-day demoLatest AMED insider trades
About AMEDISYS INC (AMED)
AMED Form 4 activity by transaction type, last 90 days
No Form 4 activity for AMED in the last 90 days.
AMED insider transactions (Form 4)
8124 Form 4 filings on record, the earliest from Nov 7, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jennifer G. Griffin - Officer | Derivative | Common Stock | 10,700 | - | - | |
| Jennifer G. Griffin - Officer | Derivative | Common Stock | 9,132 | - | - | |
| Jennifer G. Griffin - Officer | Derivative | Common Stock | 341 | - | - | |
| Jennifer G. Griffin - Officer | Derivative | Stock Option (Right to Buy) | 327 | - | - | |
| Jennifer G. Griffin - Officer | Derivative | Stock Option (Right to Buy) | 640 | - | - | |
| Jennifer G. Griffin - Officer | Derivative | Stock Option (Right to Buy) | 563 | - | - | |
| Jennifer G. Griffin - Officer | Derivative | Stock Option (Right to Buy) | 496 | - | - | |
| Allyson Guidroz - Officer | Derivative | Common Stock | 898 | - | - | |
| Allyson Guidroz - Officer | Derivative | Common Stock | 8,574 | - | - | |
| Allyson Guidroz - Officer | Derivative | Common Stock | 1.5 | - | - | |
| Allyson Guidroz - Officer | Derivative | Stock Option (Right to Buy) | 272 | - | - | |
| Allyson Guidroz - Officer | Derivative | Stock Option (Right to Buy) | 640 | - | - | |
| Allyson Guidroz - Officer | Derivative | Stock Option (Right to Buy) | 563 | - | - | |
| Allyson Guidroz - Officer | Derivative | Stock Option (Right to Buy) | 590 | - | - | |
| Nick Muscato - Officer | Derivative | Common Stock | 3,067 | - | - | |
| Nick Muscato - Officer | Derivative | Common Stock | 32,620 | - | - | |
| Nick Muscato - Officer | Option exercise | Common Stock | 3,468 | $0.00 | - | |
| Nick Muscato - Officer | Derivative | Common Stock | 3,468 | - | - | |
| Nick Muscato - Officer | Derivative | Common Stock | 212 | - | - | |
| Nick Muscato - Officer | Option exercise | Restricted Stock Unit (Performance-Based Vesting) | 3,468 | - | - | |
| Nick Muscato - Officer | Derivative | Stock Option (Right to Buy) | 272 | - | - | |
| Nick Muscato - Officer | Derivative | Stock Option (Right to Buy) | 320 | - | - | |
| Nick Muscato - Officer | Derivative | Stock Option (Right to Buy) | 563 | - | - | |
| Nick Muscato - Officer | Derivative | Stock Option (Right to Buy) | 708 | - | - | |
| Nick Muscato - Officer | Derivative | Stock Option (Right to Buy) | 2,040 | - | - | |
| Nick Muscato - Officer | Derivative | Stock Option (Right to Buy) | 2,876 | - | - | |
| Ivanetta Davis Samuels - Director | Derivative | Common Stock | 7,600 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Common Stock | 9,283 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Common Stock | 10,644 | - | - | |
| Denise M. Bohnert - Officer | Option exercise | Common Stock | 3,468 | $0.00 | - | |
| Denise M. Bohnert - Officer | Derivative | Common Stock | 3,468 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Common Stock | 214 | - | - | |
| Denise M. Bohnert - Officer | Option exercise | Restricted Stock Unit (Performance-Based Vesting) | 3,468 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 263 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 682 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 1,907 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 1,199 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 1,067 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 2,040 | - | - | |
| Denise M. Bohnert - Officer | Derivative | Stock Option (Right to Buy) | 2,876 | - | - | |
| Teresa L. Kline - Director | Derivative | Common Stock | 9,818 | - | - | |
| Jeffrey A. Rideout - Director | Derivative | Common Stock | 9,335 | - | - | |
| Richard M. Ashworth - Officer | Derivative | Common Stock | 45,870 | - | - | |
| Richard M. Ashworth - Officer | Derivative | Common Stock | 114,055 | - | - | |
| Richard M. Ashworth - Officer | Option exercise | Common Stock | 62,641 | $0.00 | - | |
| Richard M. Ashworth - Officer | Derivative | Common Stock | 62,641 | - | - | |
| Richard M. Ashworth - Officer | Option exercise | Common Stock | 39,850 | $0.00 | - | |
| Richard M. Ashworth - Officer | Derivative | Common Stock | 39,850 | - | - | |
| Richard M. Ashworth - Officer | Option exercise | Restricted Stock Unit (Performance-Based Vesting) | 62,641 | - | - | |
| Richard M. Ashworth - Officer | Option exercise | Restricted Stock Unit (Performance-Based Vesting) | 39,850 | - | - | |
| Richard M. Ashworth - Officer | Derivative | Stock Option (Right to Buy) | 22,474 | - | - | |
| Scott G. Ginn - Officer | Derivative | Common Stock | 31,211 | - | - | |
| Scott G. Ginn - Officer | Derivative | Common Stock | 60,518 | - | - | |
| Scott G. Ginn - Officer | Option exercise | Common Stock | 10,399 | $0.00 | - | |
| Scott G. Ginn - Officer | Derivative | Common Stock | 10,399 | - | - | |
| Scott G. Ginn - Officer | Derivative | Common Stock | 2,714 | - | - | |
| Scott G. Ginn - Officer | Option exercise | Restricted Stock Unit (Performance-Based Vesting) | 10,399 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 424 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 6,995 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 4,294 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 2,997 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 3,200 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 6,119 | - | - | |
| Scott G. Ginn - Officer | Derivative | Stock Option (Right to Buy) | 8,627 | - | - | |
| Julie D. Klapstein - Director | Derivative | Common Stock | 16,031 | - | - | |
| Paul B. K. Kusserow - Director | Derivative | Common Stock | 439,124 | - | - | |
| Paul B. K. Kusserow - Director | Derivative | Common Stock | 621 | - | - | |
| Paul B. K. Kusserow - Director | Derivative | Stock Option (Right to Buy) | 80,602 | - | - | |
 Molly Joel Coye - Director | Derivative | Common Stock | 8,818 | - | - | |
| Vickie L. Capps - Director | Derivative | Common Stock | 9,818 | - | - | |
| Bruce D. Perkins - Director | Derivative | Common Stock | 23,992 | - | - | |
| Allyson Guidroz - Officer | Grant or award | Common Stock | 2,015 | $0.00 | - | |
| Allyson Guidroz - Officer | Tax withholding / forfeiture | Common Stock | 25 | $97.94 | $2K | |
| Nick Muscato - Officer | Tax withholding / forfeiture | Common Stock | 31 | $97.94 | $3K | |
| Allyson Guidroz - Officer | Tax withholding / forfeiture | Common Stock | 461 | $96.38 | $44K | |
| Bruce D. Perkins - Director | Gift | Common Stock | 105 | $0.00 | - | |
| Vickie L. Capps - Director | Grant or award | Common Stock | 1,690 | $0.00 | - | |
| Bruce D. Perkins - Director | Grant or award | Common Stock | 1,690 | $0.00 | - | |
| Jennifer G. Griffin - Officer | Tax withholding / forfeiture | Common Stock | 3,507 | $89.96 | $315K | |
| Richard M. Ashworth - Officer | Tax withholding / forfeiture | Common Stock | 11,079 | $89.96 | $997K | |
| Nick Muscato - Officer | Grant or award | Common Stock | 10,421 | $0.00 | - |
AMED insider trading FAQ
What is the latest insider trade for AMED?
AMEDISYS INC (AMED) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-14. The full record for AMED runs to 24 Form 4 filings, the earliest from 2024-11-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AMED stock?
No insider purchases of AMED were filed in the last 90 days.
How many insiders are selling AMED stock?
No insider sales of AMED were filed in the last 90 days.
Where can I see AMED SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AMED Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jennifer G. Griffin view on EDGAR
- - Allyson Guidroz view on EDGAR
- - Nick Muscato view on EDGAR
- - Ivanetta Davis Samuels view on EDGAR
- - Denise M. Bohnert view on EDGAR
- - Teresa L. Kline view on EDGAR
- - Jeffrey A. Rideout view on EDGAR
- - Richard M. Ashworth view on EDGAR
- - Scott G. Ginn view on EDGAR
- - Julie D. Klapstein view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AMED's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AMED with a 7-day demo
- AMED on your watchlist
- Every AMED Form 4 filing on record
- Up to 3 months of AMED price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
